James M. Gower

2011

In 2011, James M. Gower earned a total compensation of $1.4M as Chief Executive Officer, Chairman of the Board and Director at Rigel Pharmaceuticals, a 43% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$467,208
Option Awards$322,082
Salary$648,900
Other$5,148
Total$1,443,338

Gower received $648.9K in salary, accounting for 45% of the total pay in 2011.

Gower also received $467.2K in non-equity incentive plan, $322.1K in option awards and $5.1K in other compensation.

Rankings

In 2011, James M. Gower's compensation ranked 4,354th out of 10,747 executives tracked by ExecPay. In other words, Gower earned more than 59.5% of executives.

ClassificationRankingPercentile
All
4,354
out of 10,747
60th
Division
Manufacturing
1,545
out of 3,960
61st
Major group
Chemicals And Allied Products
316
out of 1,038
70th
Industry group
Drugs
187
out of 786
76th
Industry
Pharmaceutical Preparations
145
out of 571
75th
Source: SEC filing on April 8, 2014.

Gower's colleagues

We found four more compensation records of executives who worked with James M. Gower at Rigel Pharmaceuticals in 2011.

2011

Raul Rodriguez

Rigel Pharmaceuticals

Chief Operating Officer

2011

Donald Payan

Rigel Pharmaceuticals

Executive Vice President, President of Discovery and Research

2011

Elliott Grossbard

Rigel Pharmaceuticals

Chief Medical Officer

2011

Ryan Maynard

Rigel Pharmaceuticals

Chief Financial Officer

You may also like